Expression Patterns of Immune Genes Reveal Heterogeneous Subtypes of High-Risk Neuroblastoma

Expression Patterns of Immune Genes Reveal Heterogeneous Subtypes of High-Risk Neuroblastoma

High risk neuroblastoma (HR-NB) remains difficult to treat, and its overall survival (OS) is still below 50%. Although HR-NB is a heterogeneous disease, HR-NB patients are currently treated in a similar fashion. Through unsupervised biclustering, we further stratified HR-NB patients into two reprodu...

Full description

Bibliographic Details
Main Authors:	Zhenqiu Liu, Christa N. Grant, Lidan Sun, Barbara A. Miller, Vladimir S. Spiegelman, Hong-Gang Wang
Format:	Article
Language:	English
Published:	MDPI AG 2020-06-01
Series:	Cancers
Subjects:	ultra-high risk neuroblastoma clinically distinct subtypes immune-related gene signatures prognostic markers biclustering TP53 signaling
Online Access:	https://www.mdpi.com/2072-6694/12/7/1739

Similar Items

The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53
by: Joanna S. Yi, et al.
Published: (2021-06-01)

Combined ALK and MDM2 inhibition increases antitumor activity and overcomes resistance in human ALK mutant neuroblastoma cell lines and xenograft models
by: Hui Qin Wang, et al.
Published: (2017-04-01)

Construction and Validation of a Reliable Six-Gene Prognostic Signature Based on the TP53 Alteration for Hepatocellular Carcinoma
by: Junyu Huo, et al.
Published: (2021-06-01)

Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes
by: Lan Zhao, et al.
Published: (2018-05-01)

Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma
by: Hao Sun, et al.
Published: (2020-10-01)

Analysis of breast cancer subtypes by AP-ISA biclustering
by: Liying Yang, et al.
Published: (2017-11-01)

Interpretable models for high-risk neuroblastoma stratification with multi-cohort copy number profiles
by: Zhenqiu Liu, et al.
Published: (2021-01-01)

Significance of miR-885-5p in neuroblastoma outcome
by: M. Inomistova, et al.
Published: (2015-12-01)

Molecular Subtypes Based on the Stemness Index Predict Prognosis in Glioma Patients
by: Jun Tan, et al.
Published: (2021-03-01)

Investigation of colorectal cancer in accordance with consensus molecular subtype classification
by: Hiroshi Sawayama, et al.
Published: (2020-09-01)

Comparative Analysis of Putative Prognostic and Predictive Markers in Neuroblastomas: High Expression of PBX1 Is Associated With a Poor Response to Induction Therapy
by: Renata Veselska, et al.
Published: (2019-11-01)

The prognostic values of the expression of Vimentin, TP53, and Podoplanin in patients with cervical cancer
by: Jiaying Lin, et al.
Published: (2017-09-01)

Identification and Validation of a Novel Six-Gene Prognostic Signature of Stem Cell Characteristic in Colon Cancer
by: Yichao Liang, et al.
Published: (2021-02-01)

Stage 4 s neuroblastoma: features, management and outcome of 268 cases from the Italian Neuroblastoma Registry
by: Bruno De Bernardi, et al.
Published: (2019-01-01)

Survival of children with neuroblastoma treated at the Institute of oncology in Ljubljana in two periods
by: Jasna Perković, et al.
Published: (2014-04-01)

Predicting clinical outcomes in neuroblastoma with genomic data integration
by: Ilyes Baali, et al.
Published: (2018-09-01)

REW-ISA: unveiling local functional blocks in epi-transcriptome profiling data via an RNA expression-weighted iterative signature algorithm
by: Lin Zhang, et al.
Published: (2020-10-01)

The Over-Expression of E2F3Might Serve as Prognostic Marker for Neuroblastoma Patients with Stage 4S Disease
by: Stefano Parodi, et al.
Published: (2020-05-01)

Computational Identification of Gene Networks as a Biomarker of Neuroblastoma Risk
by: Lidan Sun, et al.
Published: (2020-07-01)

Distinguishing Glioblastoma Subtypes by Methylation Signatures
by: Yu-Hang Zhang, et al.
Published: (2020-11-01)

Concurrent <i>TP53</i> and <i>CDKN2A</i> Gene Aberrations in Newly Diagnosed Mantle Cell Lymphoma Correlate with Chemoresistance and Call for Innovative Upfront Therapy
by: Diana Malarikova, et al.
Published: (2020-07-01)

Prognostic Value of Inflammation Biomarkers for Survival of Patients with Neuroblastoma
by: Zheng C, et al.
Published: (2020-04-01)

Expression level of quiescin sulfhydryl oxidase 1 (QSOX1) in neuroblastomas
by: D.G.B. Araújo, et al.
Published: (2014-03-01)

Identification of prognostic long noncoding RNAs associated with spontaneous regression of neuroblastoma
by: Xinyao Meng, et al.
Published: (2020-06-01)

Summarization Of Real Valued Biclusters
by: Subramanian, Hema
Published: (2011)

<em>TP53</em> as clinical marker in head and neck cancer
by: Peltonen, J. (Jenni)
Published: (2011)

Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma
by: Venkatesh Kancherla, et al.
Published: (2018-02-01)

Distinct signatures of the immune responses in low risk versus high risk neuroblastoma
by: Wang Ena, et al.
Published: (2011-10-01)

Immunoexpression of cell cycle biomarkers in neuroblastoma samples and its correlation with prognostic factors Imunoexpressão de biomarcadores do ciclo celular em amostras de neuroblastomas e sua relação com fatores prognósticos
by: Lúcia de Noronha, et al.
Published: (2013-02-01)

Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
by: Eunjin Lee, et al.
Published: (2020-11-01)

Cancer Stem Cells in Neuroblastoma: Expanding the Therapeutic Frontier
by: Hisham F. Bahmad, et al.
Published: (2019-05-01)

Identification of Potential Prognostic Genes for Neuroblastoma
by: Xiaodan Zhong, et al.
Published: (2018-11-01)

Discovery of Spatial Peptide Signatures for Neuroblastoma Risk Assessment by MALDI Mass Spectrometry Imaging
by: Zhiyang Wu, et al.
Published: (2021-06-01)

Biclustering of the Gene Expression Data by Coevolution Cuckoo Search
by: Lu Yin, et al.
Published: (2015-06-01)

Identification of Distinct Molecular Subtypes of Endometrioid Adenocarcinoma
by: Jia Lei, et al.
Published: (2021-07-01)

A Molecular Model for Predicting Overall Survival in Patients with Metastatic Clear Cell Renal Carcinoma: Results from CALGB 90206 (Alliance)
by: Hyung L. Kim, et al.
Published: (2015-11-01)

Olfactory Neuroblastoma
by: Jose M. Carnate
Published: (2010-12-01)

Olfactory Neuroblastoma
by: Ian C. Bickle
Published: (2016-06-01)

Identification of Distinct Molecular Patterns and a Four-Gene Signature in Colon Cancer Based on Invasion-Related Genes
by: Yunfei Dong, et al.
Published: (2021-08-01)

PRIMA-1MET-induced neuroblastoma cell death is modulated by p53 and mycn through glutathione level
by: Vid Mlakar, et al.
Published: (2019-02-01)

Cannot write session to /tmp/vufind_sessions/sess_sepr9moq40vbuq05sl1k4887tu